NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma.
Murayama Y, Kasahara Y, Kubo N, Shin C, Imamura M, Oike N, Ariizumi T, Saitoh A, Baba M, Miyazaki T, Suzuki Y, Ling Y, Okuda S, Mihara K, Ogose A, Kawashima H, Imai C.
Murayama Y, et al. Among authors: mihara k.
Transl Oncol. 2022 Nov;25:101521. doi: 10.1016/j.tranon.2022.101521. Epub 2022 Aug 20.
Transl Oncol. 2022.
PMID: 35998437
Free PMC article.